Intact carrageenan-induced thermal hyperalgesia in mice lacking inducible nitric oxide synthase

Neuroscience

Volumn 120, Issue 3, 2003, Pages 847-854

  Tao, F ^a   Tao, Y X ^a   Mao, P ^a   Zhao, C ^a   Li, D ^a   Liaw, W J ^a   Raja, S N ^a   Johns, R A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Central sensitization; Inflammation; Intrathecal injection; Nitric oxide; Persistent pain

Indexed keywords

7 NITROINDAZOLE; CARRAGEENAN; LYSINE DERIVATIVE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; ORNITHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; CHRONIC PAIN; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DISRUPTION; GENE TARGETING; GENOMICS; HYPERALGESIA; INFLAMMATION; KNOCKOUT MOUSE; LUMBAR SPINE; MALE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; TEMPERATURE DEPENDENCE; WILD TYPE;

EID: 0042266291     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00362-2     Document Type: Article

References (48)

1. Barker J.E., Strangward H.M., Brand M.P., Hurst R.D., Land J.M., Clark J.B., et al. Increased inducible nitric oxide synthase protein but limited nitric oxide formation occurs in astrocytes of the hph-1 (tetrahydrobiopterin deficient) mouse. Brain Res. 804:1998;1-6.
2. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1990;682-685.
3. Budzinski M., Misterek K., Gumulka W., Dorociak A. Inhibition of inducible nitric oxide synthase in persistent pain. Life Sci. 66:2000;301-305.
4. Eisenberg E., LaCross S., Strassman A.M. The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats. Eur J Pharmacol. 255:1994;123-129.
5. Ferreira J., Santos A.R.S., Calixto J.B. The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice. Neuropharmacology. 38:1999;835-842.
6. Furuyama T., Inagaki S., Takagi H. Localizations of alpha 1 and beta 1 subunits of soluble guanylate cyclase in the rat brain. Brain Res Mol Brain Res. 20:1993;335-344.
7. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature. 336:1988;385-388.
8. Guhring H., Tegeder I., Lotsch J., Pahl A., Werner U., Reeh P.W., et al. Role of nitric oxide in zymosan induced paw inflammation and thermal hyperalgesia. Inflamm Res. 50:2001;83-88.
9. Guhring H., Gorig M., Ates M., Coste O., Zeilhofer H.U., Pahl A., et al. Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci. 20:2000;6714-6720.
10. Handy R.L.C., Moore P.K. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol. 123:1998;1119-1126.
11. Handy R.L.C., Moore P.K. Effects of selective inhibitors of neuronal nitric oxide synthase on carrageenan-induced mechanical and thermal hyperalgesia. Neuropharmacology. 37:1998;37-43.
12. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
13. Heales S.J., Bolanos J.P., Stewart V.C., Brookes P.S., Land J.M., Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta. 1410:1999;215-228.
14. Hedo G., Laird J.M., Lopez-Garcia J.A. Time-course of spinal sensitization following carrageenan-induced inflammation in the young rat a comparative electrophysiological and behavioral study in vitro and in vivo . Neuroscience. 92:1999;309-318.
15. Heneka M.T., Feinstein D.L. Expression and function of inducible nitric oxide synthase in neurons. J Neuroimmunol. 114:2001;8-18.
16. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice a new technique . Eur J Pharmacol. 67:1980;313-316.
17. Jiang M.H., Kaku T., Hada J., Hayashi Y. Different effects of eNOS and nNOS inhibition on transient forebrain ischemia. Brain Res. 946:2002;139-147.
18. Kolhekar R., Murphy S., Gebhart G.F. Thalamic NMDA receptors modulate inflammation-produced hyperalgesia in the rat. Pain. 71:1997;31-40.
19. Larson A.A., Kovacs K.J., Cooper J.C., Kitto K.F. Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice. Pain. 86:2000;103-111.
20. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA. 92:1995;10688-10692.
21. Lawand N.B., Willis W.D., Westlund K.N. Blockade of joint inflammation and secondary hyperalgesia by L-NAME, a nitric oxide synthase inhibitor. Neuroreport. 8:1997;895-899.
22. Lin Q., Peng Y.B., Wu J., Willis W.D. Involvement of cGMP in nociceptive processing by and sensitization of spinothalamic neurons in primates. J Neurosci. 17:1997;3293-3302.
23. Malmberg A.B., Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain. 54:1993;291-300.
24. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 60:1994;367-374.
25. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
26. Meller S.T., Dykstra C., Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur J Pharmacol. 214:1992;93-96.
27. Moore P.K., Oluyomi A.O., Babbedge R.C., Wallace P., Hart S.L. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol. 102:1991;198-202.
28. Moore P.K., Wallace P., Gaffen Z.A., Hart S.L., Babbedge R.C. 7-nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol. 108:1993;296-297.
29. 6-(1-iminoethyl)lysine a selective inhibitor of inducible nitric oxide synthase . J Med Chem. 37:1994;3886-3888.
30. Osborne M.G., Coderre T.J. Effects of intrathecal administration of nitric oxide synthase inhibitors on carrageenan-induced thermal hyperalgesia. Br J Pharmacol. 126:1999;1840-1846.
31. Paul-Clark M.J., Gilroy D.W., Willis D., Willoughby D.A., Tomlinson A. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. J Immunol. 166:2001;1169-1177.
32. Prast H., Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol. 64:2001;51-68.
33. Rivot J.P., Sousa A., Montagne-Clavel J., Besson J.M. Nitric oxide (NO) release by glutamate and NMDA in the dorsal horn of the spinal cord an in vivo electrochemical approach in the rat . Brain Res. 821:1999;101-110.
34. Roche A.K., Cook M., Wilcox G.L., Kajander K.C. A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain. 66:1996;331-341.
35. Rygh L.J., Svendsen F., Hole K., Tjolsen A. Increased spinal NMDA receptor function after 20 h of carrageenan-induced inflammation. Pain. 93:2001;15-21.
36. Salerno L., Sorrenti V., Di Giacomo C., Romeo G., Siracusa M.A. Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des. 8:2002;177-200.
37. Semos M.L., Headley P.M. The role of nitric oxide in spinal nociceptive reflexes in rats with neurogenic and non-neurogenic peripheral inflammation. Neuropharmacology. 33:1994;1487-1497.
38. Snyder S.H. Nitric oxide first in a new class of neurotransmitters . Science. 41:1992;494-496.
39. Tao F., Tao Y.-X., Gonzalez J.A., Fang M., Mao P., Johns R.A. Knockdown of PSD-95/SAP90 delays the development of neuropathic pain in rats. Neuroreport. 12:2001;3251-3255.
40. Tao Y.-X., Johns R.A. Activation and up-regulation of spinal cord nitric oxide receptor, soluble guanylate cyclase, after formalin injection into the rat hind paw. Neuroscience. 112:2002;439-446.
41. Tao Y.-X., Hassan A., Haddad E., Johns R.A. Expression and action of cyclic GMP-dependent protein kinase Iα in inflammatory hyperalgesia in rat spinal cord. Neuroscience. 95:2000;525-533.
42. Tao Y.-X., Johns R.A. Activation of cGMP-dependent protein kinase Iα is required for N-methyl-D-aspartate- or nitric oxide-produced spinal thermal hyperalgesia. Eur J Pharmacol. 392:2000;141-145.
43. Traub R.J., Solodkin A., Meller S.T., Gebhart G.F. Spinal cord NADPH-diaphorase histochemical staining but not nitric oxide synthase immunoreactivity increases following carrageenan-produced hindpaw inflammation in the rat. Brain Res. 668:1994;204-210.
44. Wei G., Dawson V.L., Zweier J.L. Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochi Biophy Acta. 1455:1999;23-34.
45. Willenborg D.O., Fordham S.A., Staykova M.A., Ramshaw I.A., Cowden W.B. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue a possible role for nitric oxide . J Immunol. 163:1999;5278-5286.
46. Winkler T., Sharma H.S., Stalberg E., Badgaiyan R.D., Alm P., Westman J. Spinal cord evoked potentials and edema in the pathophysiology of rat spinal cord injury involvement of nitric oxide . Amino Acids. 14:1998;131-139.
47. Wu J., Lin Q., Lu Y., Willis W.D., Westlund K.N. Changes in nitric oxide synthase isoforms in the spinal cord of rat following induction of chronic arthritis. Exp Brain Res. 118:1998;457-465.
48. Wu J., Fang L., Lin Q., Willis W.D. Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin. Pain. 94:2001;47-58.